News Releases

Anixa Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference

January 5, 2021

Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine

December 21, 2020

Anixa Biosciences Covid-19 Therapy Demonstrates Comparable Potency to Remdesivir in Pre-Clinical Testing

December 14, 2020

Anixa Biosciences Announces Licensing Agreement with Cleveland Clinic for Ovarian Cancer Vaccine Technology

December 1, 2020

Anixa Biosciences and Cleveland Clinic File IND Application for Breast Cancer Vaccine

November 23, 2020

Anixa Biosciences to Host Conference Call to Provide Update on Programs

October 27, 2020

Anixa Biosciences to Present at the 2020 H.C. Wainwright 22nd Annual Global Investment Conference

September 8, 2020

Anixa and OntoChem Announce Identification of Additional Covid-19 Compounds

August 13, 2020

Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission

July 28, 2020

Anixa Biosciences Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders

July 20, 2020

« Previous
1...
2
3
4
5
6
7
8
9
10
11
...22
Next »

Latest News & Events

Sep 19, 2023

Anixa Biosciences Establishes Cancer Business Advisory Board

Read More...

Aug 31, 2023

Anixa Biosciences to Participate in September Investor Conferences

Read More...

Aug 28, 2023

Anixa Biosciences Announces Treatment of Third Patient in Ovarian Cancer CAR-T Clinical Trial

Read More...